{"DataElement":{"publicId":"5485933","version":"1","preferredName":"Clinical Course of Disease Assessment Method Prognostic Score Type","preferredDefinition":"A description of the clinical course of disease prognostic score assessment method.","longName":"5485864v1.0:5599429v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5485864","version":"1","preferredName":"Clinical Course of Disease Assessment Method","preferredDefinition":"A term that refers to the nature and/or clinical outcome of a disease (e.g., acute or chronic disease, aggressive or indolent disease, recurrent disease, etc.)._The final result of a determination of the value, significance, or extent of._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","longName":"5485862v1.0:2730351v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5485862","version":"1","preferredName":"Clinical Course of Disease Assessment","preferredDefinition":"A term that refers to the nature and/or clinical outcome of a disease (e.g., acute or chronic disease, aggressive or indolent disease, recurrent disease, etc.).:The final result of a determination of the value, significance, or extent of.","longName":"C35461:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Course of Disease","conceptCode":"C35461","definition":"A term that refers to the nature and/or clinical outcome of a disease (e.g., acute or chronic disease, aggressive or indolent disease, recurrent disease, etc.).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D7DC96F-624B-3042-E053-F662850ABE39","latestVersionIndicator":"Yes","beginDate":"2016-09-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-09-27","modifiedBy":"ONEDATA","dateModified":"2016-09-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2730351","version":"1","preferredName":"Method","preferredDefinition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","longName":"C71460","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Method","conceptCode":"C71460","definition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4692C84F-EB01-324C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-02-20","modifiedBy":"ONEDATA","dateModified":"2008-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D7DC96F-6259-3042-E053-F662850ABE39","latestVersionIndicator":"Yes","beginDate":"2016-09-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-09-27","modifiedBy":"NYCHM","dateModified":"2017-02-03","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5599429","version":"1","preferredName":"Prognostic Assessment Score Type","preferredDefinition":"Having value for making predictions._The final result of a determination of the value, significance, or extent of._A number or range of numeric values measuring performance, function, quality, or ability._Something distinguishable as an identifiable class based on common qualities.","longName":"5599429v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"EUTOS","valueDescription":"European Treatment Outcome Study Score","ValueMeaning":{"publicId":"5485918","version":"1","preferredName":"European Treatment Outcome Study Score","longName":"5485918","preferredDefinition":"A method for assessing prognosis for patients with chronic myeloid leukemia. Patients are classified as a high or low risk on the basis of the percentage of basophils in the peripheral blood and spleen size at diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Treatment Outcome Study Score","conceptCode":"C127872","definition":"A method for assessing prognosis for patients with chronic myeloid leukemia. Patients are classified as a high or low risk on the basis of the percentage of basophils in the peripheral blood and spleen size at diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D7F64DB-84CD-4E54-E053-F662850A50F7","latestVersionIndicator":"Yes","beginDate":"2016-09-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2016-09-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"433D5EEB-F4C0-01CE-E053-F662850A5F74","beginDate":"2016-12-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-09","modifiedBy":"ONEDATA","dateModified":"2016-12-09","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"433D5EEB-F4CD-01CE-E053-F662850A5F74","beginDate":"2016-12-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-09","modifiedBy":"ONEDATA","dateModified":"2016-12-09","deletedIndicator":"No"},{"value":"Sokal","valueDescription":"Sokal Score","ValueMeaning":{"publicId":"5485916","version":"1","preferredName":"Sokal Score","longName":"5485916","preferredDefinition":"A method for assessing prognosis for patients with chronic myeloid leukemia. The numerical value is calculated at diagnosis from the percentage of blast cells in peripheral blood, the platelet count, the spleen size, and the age of the patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sokal Score","conceptCode":"C127875","definition":"A method for assessing prognosis for patients with chronic myeloid leukemia. The numerical value is calculated at diagnosis from the percentage of blast cells in peripheral blood, the platelet count, the spleen size, and the age of the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D7F64DB-8483-4E54-E053-F662850A50F7","latestVersionIndicator":"Yes","beginDate":"2016-09-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2016-09-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"433D5EEB-F4D7-01CE-E053-F662850A5F74","beginDate":"2016-12-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-09","modifiedBy":"ONEDATA","dateModified":"2016-12-09","deletedIndicator":"No"},{"value":"Hasford","valueDescription":"Hasford Score","ValueMeaning":{"publicId":"5485917","version":"1","preferredName":"Hasford Score","longName":"5485917","preferredDefinition":"A method for assessing prognosis for patients with chronic myeloid leukemia. Patients are classified as a high, medium, or low risk on the basis of age, spleen size, and eosinophil, basophil, and platelet counts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hasford Score","conceptCode":"C127873","definition":"A method for assessing prognosis for patients with chronic myeloid leukemia. Patients are classified as a high, medium, or low risk on the basis of age, spleen size, and eosinophil, basophil, and platelet counts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D7F64DB-84A8-4E54-E053-F662850A50F7","latestVersionIndicator":"Yes","beginDate":"2016-09-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2016-09-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"433D5EEB-F4E1-01CE-E053-F662850A5F74","beginDate":"2016-12-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-09","modifiedBy":"ONEDATA","dateModified":"2016-12-09","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"433D5EEB-F4EC-01CE-E053-F662850A5F74","beginDate":"2016-12-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-09","modifiedBy":"ONEDATA","dateModified":"2016-12-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5599428","version":"1","preferredName":"Prognostic Assessment Score Type","preferredDefinition":"Having value for making predictions.:The final result of a determination of the value, significance, or extent of.:A number or range of numeric values measuring performance, function, quality, or ability.:Something distinguishable as an identifiable class based on common qualities.","longName":"C25263:C25217:C25338:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prognostic","conceptCode":"C25263","definition":"Having value for making predictions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"433D5EEB-F395-01CE-E053-F662850A5F74","latestVersionIndicator":"Yes","beginDate":"2016-12-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-09","modifiedBy":"ONEDATA","dateModified":"2016-12-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"433D5EEB-F3A6-01CE-E053-F662850A5F74","latestVersionIndicator":"Yes","beginDate":"2016-12-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-09","modifiedBy":"NYCHM","dateModified":"2017-02-02","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CMLP_DADX_dis_crse_assess_meth","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the clinical course","type":"Preferred Question Text","description":"What was the clinical course of disease prognostic score assessment method?","url":null,"context":"NHLBI"},{"name":"Specify the chronic phase risk score used:","type":"Alternate Question Text","description":"Specify the chronic phase risk score used:","url":null,"context":"NHLBI"},{"name":"Specify the chronic phase risk score used","type":"Application Standard Question Text","description":"Specify the chronic phase risk score used","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D803AA0-B608-686C-E053-F662850A70E0","latestVersionIndicator":"Yes","beginDate":"2016-09-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-09-27","modifiedBy":"NYCHM","dateModified":"2017-02-03","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}